Mohamad Makhzoumi

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohamad Makhzoumi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 7,692,298 $146,153,662 $19.00 28 Jun 2021 Indirect
Savara Inc 10%+ Owner Common Stock 24,471,264 $108,897,125 $4.45 17 Jul 2023 Indirect
Korro Bio, Inc. 10%+ Owner Common Stock 1,090,793 $61,084,408 $56.00 22 Apr 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3,614,486 $38,638,855 $10.69 16 Sep 2024 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Common Stock 1,357,263 $37,772,629 $27.83 09 Feb 2026 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 12,273,280 $16,814,393 $1.37 17 Apr 2025 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2,563,257 $1,204,731 $0.4700 22 Dec 2021 Indirect
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 11,348 $318,142 $28.04 13 Jun 2023 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 6,371 $78,259 $12.28 02 May 2022 Direct
NeueHealth, Inc. Director, 10%+ Owner Restricted Stock Units 0 $76,335 $7.27 13 May 2025 Direct
IonQ, Inc. 10%+ Owner Common Stock 1,654 $21,855 $13.21 16 Nov 2022 Direct
Arcellx, Inc. 10%+ Owner Common Stock 283 $15,641 $55.27 20 Dec 2022 Direct
IonQ, Inc. 10%+ Owner Common Stock 1,047 $13,834 $13.21 16 Nov 2022 Indirect
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 559 $8,385 $15.00 19 Oct 2022 Direct
AVEO PHARMACEUTICALS, INC. 10%+ Owner Common Stock 354 $5,310 $15.00 19 Oct 2022 Indirect
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 1,273 $933 $0.7332 08 Jun 2021 Direct
Desktop Metal, Inc. 10%+ Owner Class A Common Stock 806 $591 $0.7332 08 Jun 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Direct
NeueHealth, Inc. Director, 10%+ Owner Common Stock 0 $0 $6.84 02 Oct 2025 Indirect
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 30 Nov 2022 Indirect
Arcellx, Inc. 10%+ Owner Common Stock 0 $55.27 21 Dec 2022 Indirect
Eargo, Inc. 10%+ Owner Common Stock 0 $2.59 25 May 2021 Direct
Eargo, Inc. 10%+ Owner Common Stock 0 $2.59 24 May 2021 Indirect
GENOCEA BIOSCIENCES, INC. 10%+ Owner Common Stock 0 $1.25 25 May 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 16 Sep 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 16 Sep 2024 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series A-2 convertible preferred stock 0 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 $2.00 28 Jun 2021 Indirect
Monte Rosa Therapeutics, Inc. 10%+ Owner Series C convertible preferred Stock 0 28 Jun 2021 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series A Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Series B Convertible Perpetual Preferred Stock 0 02 Oct 2025 Indirect
NeueHealth, Inc. Director, 10%+ Owner Warrant (Right to Buy) 0 02 Oct 2025 Indirect
Robinhood Markets, Inc. Director Class A Common Stock 0 $12.28 03 May 2022 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Series A Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Series B Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Series C-1 Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Series C-2 Preferred Stock 0 09 Feb 2026 Indirect
SpyGlass Pharma, Inc. 10%+ Owner Series D Preferred Stock 0 09 Feb 2026 Indirect
Trevi Therapeutics, Inc. 10%+ Owner 3.5-Year Common Stock Warrant 0 17 Apr 2025 Indirect

Insider Reports Filed by Mohamad Makhzoumi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGP SpyGlass Pharma, Inc. 09 Feb 2026 13 +$15,000,000 4 10%+ Owner 11 Feb 2026, 16:30
SGP SpyGlass Pharma, Inc. 05 Feb 2026 0 $0 3 10%+ Owner 05 Feb 2026, 16:05
TRVI Trevi Therapeutics, Inc. 31 Dec 2025 2 +$2,537,037 5 10%+ Owner 13 Feb 2026, 16:30
NEUE NeueHealth, Inc. 02 Oct 2025 41 +$19.5 4 Director, 10%+ Owner 06 Oct 2025, 17:54
NEUE NeueHealth, Inc. 13 May 2025 2 $0 4 Director, 10%+ Owner 15 May 2025, 18:18
NEUE NeueHealth, Inc. 01 Oct 2024 4 $0 4 Director, 10%+ Owner 03 Oct 2024, 18:25
MBX MBX Biosciences, Inc. 16 Sep 2024 5 +$8,000,000 4 10%+ Owner 17 Sep 2024, 20:20
MBX MBX Biosciences, Inc. 12 Sep 2024 0 $0 3 10%+ Owner 12 Sep 2024, 19:29
NEUE NeueHealth, Inc. 12 May 2024 3 $0 4 Director, 10%+ Owner 14 May 2024, 20:25
KRRO Korro Bio, Inc. 22 Apr 2024 1 +$999,992 4 10%+ Owner 24 Apr 2024, 17:00
NEUE NeueHealth, Inc. 08 Apr 2024 4 $0 4 Director, 10%+ Owner 10 Apr 2024, 19:17
NEUE Bright Health Group Inc. 19 Dec 2023 1 $0 4 Director, 10%+ Owner 21 Dec 2023, 17:00
KRRO Korro Bio, Inc. 03 Nov 2023 0 $0 3 10%+ Owner 07 Nov 2023, 21:30
NEUE Bright Health Group Inc. 31 Oct 2023 1 $0 4 Director, 10%+ Owner 02 Nov 2023, 18:43
NEUE Bright Health Group Inc. 15 Sep 2023 1 $0 4 Director, 10%+ Owner 19 Sep 2023, 18:23
NEUE Bright Health Group Inc. 11 Aug 2023 1 $0 4 Director, 10%+ Owner 15 Aug 2023, 21:56
SVRA Savara Inc 17 Jul 2023 1 +$999,999 4 10%+ Owner 19 Jul 2023, 19:09
MIRM Mirum Pharmaceuticals, Inc. 13 Jun 2023 5 $0 4 10%+ Owner 15 Jun 2023, 16:34
NEUE Bright Health Group Inc. 12 May 2023 3 $0 4 Director, 10%+ Owner 16 May 2023, 20:46
ACLX Arcellx, Inc. 20 Dec 2022 6 -$5,502 4 10%+ Owner 22 Dec 2022, 17:47
/report/000120919122059454-makhzoumi-mohamad-2022-11-30 Akouos, Inc. 30 Nov 2022 1 $0 4 10%+ Owner 02 Dec 2022, 16:07
IONQ IonQ, Inc. 16 Nov 2022 5 $0 4 10%+ Owner 18 Nov 2022, 16:11
/report/000120919122054290-makhzoumi-mohamad-2022-10-19 AVEO PHARMACEUTICALS, INC. 19 Oct 2022 7 $0 4 10%+ Owner 21 Oct 2022, 16:50
NEUE Bright Health Group Inc. 17 Oct 2022 2 +$137,700,000 4 Director, 10%+ Owner 19 Oct 2022, 19:58
/report/000120919122032326-makhzoumi-mohamad-2022-05-24 GENOCEA BIOSCIENCES, INC. 24 May 2022 2 -$750,662 4 10%+ Owner 26 May 2022, 18:25
NEUE Bright Health Group Inc. 13 May 2022 1 $0 4 Director, 10%+ Owner 17 May 2022, 20:10
HOOD Robinhood Markets, Inc. 02 May 2022 9 -$19,640 4 Director 04 May 2022, 19:46
TRVI Trevi Therapeutics, Inc. 11 Apr 2022 3 +$12,499,999 4 10%+ Owner 13 Apr 2022, 17:21
HOOD Robinhood Markets, Inc. 28 Jan 2022 9 -$29,598 4 Director 01 Feb 2022, 18:21
NEUE Bright Health Group Inc. 03 Jan 2022 2 +$200,000,000 4 Director, 10%+ Owner 05 Jan 2022, 16:50
/report/000120919121071270-makhzoumi-mohamad-2021-12-10 Metacrine, Inc. 10 Dec 2021 3 -$494,483 4 10%+ Owner 27 Dec 2021, 15:44
HOOD Robinhood Markets, Inc. 10 Nov 2021 4 $0 4 Director 12 Nov 2021, 15:39
HOOD Robinhood Markets, Inc. 27 Oct 2021 4 $0 4 Director, 10%+ Owner 29 Oct 2021, 17:17
TRVI Trevi Therapeutics, Inc. 18 Oct 2021 3 $0 4 10%+ Owner 19 Oct 2021, 21:14
HOOD Robinhood Markets, Inc. 02 Aug 2021 20 +$77,118,720 4 Director, 10%+ Owner 03 Aug 2021, 17:50
HOOD Robinhood Markets, Inc. 29 Jul 2021 0 $0 3 Director, 10%+ Owner 29 Jul 2021, 17:52
NEUE Bright Health Group Inc. 28 Jun 2021 22 +$34,999,992 4 Director, 10%+ Owner 30 Jun 2021, 21:31
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 +$19,950,000 4 10%+ Owner 30 Jun 2021, 18:05
NEUE Bright Health Group Inc. 24 Jun 2021 0 $0 3 Director, 10%+ Owner 24 Jun 2021, 21:27
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 10%+ Owner 23 Jun 2021, 21:09
DM Desktop Metal, Inc. 08 Jun 2021 5 $0 4 10%+ Owner 10 Jun 2021, 16:40
/report/000120919121035938-makhzoumi-mohamad-2021-05-24 Eargo, Inc. 24 May 2021 5 -$9,172 4 10%+ Owner 26 May 2021, 16:37